K. Kaiser

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Mary J. Fidler, Athanassios Argiris, Jyoti D. Patel et al. · Clinical Cancer Research · 2008 · 56 citations · Full text

Medicine, Oncology, Pharmacology +16

The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with Gefitinib

Lela Buckingham, John S. Coon, Larry E. Morrison et al. · Journal of Thoracic Oncology · 2007 · 40 citations · Full text

Life Sciences, Genetics, Oncology +13

EGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts)

Victoria Villaflor, Lela Buckingham, M. Gale et al. · Journal of Clinical Oncology · 2005 · 12 citations

Medicine, Oncology, Pharmacotherapy +15

Insulin-like growth factor receptor 1 (IGFR-1) and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with gefitinib

Mary J. Fidler, Sanjib Basu, Lela Buckingham et al. · Journal of Clinical Oncology · 2008 · 11 citations

Medicine, Oncology, Pharmacotherapy +16